X-linked adrenoleukodystrophy (X-ALD) and metachromatic leukodystrophy (MLD) are two relatively common examples of hereditary demyelinating diseases caused by a dysfunction of peroxisomal or lysosomal lipid degradation. In both conditions, accumulation of nondegraded lipids leads to the destruction of cerebral white matter. Because of their high lipid content, oligodendrocytes are considered key to the pathophysiology of these leukodystrophies. However, the response to allogeneic stem cell transplantation points to the relevance of cells related to the hematopoietic lineage. In the present study, we aimed to better characterize the pathogenetic role of microglia in the above-mentioned diseases. Applying recently established microglia markers to human autopsy cases of X-ALD and MLD we were able to delineate distinct lesion stages in evolving demyelinating lesions. The immune-phenotype of microglia was altered already early in lesion evolution, and microglia loss preceded full-blown myelin degeneration both in X-ALD and MLD. DNA fragmentation indicating phagocyte death was observed in areas showing microglia loss.
| INTRODUCTION
X-linked adrenoleukodystrophy (X-ALD), the most common peroxisomal storage disease (Berger, Pujol, Aubourg, & Forss-Petter, 2010) , is caused by a dysfunction of ABCD1 transporters, which normally shuttle activated very long chain fatty acids (VLCFA) into the peroxisome for further degradation. At least 60% of affected male individuals develop cerebral adrenoleukodystrophy (Beer, Engelen, & van Geel, 2014; Wiesinger, Eichler, & Berger, 2015) . Left untreated, the disease has an infaust prognosis, resulting in severe destruction of cerebral white matter (Mahmood, Raymond, Dubey, Peters, & Moser, 2007) . Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disorder with a mutation in the gene encoding the enzyme arylsulfatase A (ARSA) (Gieselmann et al., 1991) . This leads to an accumulation of sulfatides, with destruction of cerebral white matter as a salient end-stage pathology.
Mature oligodendrocytes sustain myelin sheaths with a high lipid content, representing 70-75% of their dry weight (Nave & Werner, 2014) . In addition, most sulfatides in the CNS are located in the myelin sheaths and oligodendrocytes (Eckhardt, 2008) . Accordingly, this cell type is considered central to the pathogenesis of leukodystrophies (Gieselmann, 2008) . However, the fact that these diseases partly respond to allogeneic or genetically modified autologous stem cell transplantation Kidd et al., 1998; Peters et al., 2004) underscores the fundamental importance of cells derived from-or replaceable bydescendants of the hematopoietic lineage. In addition, some more recent studies in animal models and in human tissue highlight early changes of microglia in lesion development (Eichler et al., 2008; Gong et al., 2017; Wittke, Hartmann, Gieselmann, & Lüllmann-Rauch, 2004 ).
The transmembrane protein 119 (Tmem119) and the purinergic receptor P2ry12 are two recently discovered cell surface proteins highly expressed in brain resident microglia under homeostatic conditions as opposed to peripheral macrophages (Bennett et al., 2016; Butovsky et al., 2014; Sasaki et al., 2003) . In the present study, we sought to characterize and compare human cases of X-ALD and MLD by using these new in addition to established phagocyte markers.
We observed striking early changes in the immune phenotype of microglia in X-ALD and MLD that preceded signs of overt myelin damage. These changes in microglia expression patterns allowed a more precise assessment of lesion evolution. In X-ALD, in addition, a severe reduction in microglia density preceded full-blown oligodendrocyte and myelin degeneration. In MLD, phagocyte death was accompanied by lysosomal breakdown and cell membrane lysis and was observed before oligodendrocyte damage and reduction in myelin density. Morphological and histochemical features of cell death varied between the diseases and between lesion stages in a particular disease.
The finding of primary microglia damage in X-ALD and MLD, where toxic substrates are known to be mainly synthesized in oligodendrocytes and myelin, indicates a shed of undegradable and toxic lipids from myelinating cells and supports the hypothesis that turnover of myelin is outsourced to microglia cells.
| MATERIALS AND METHODS

| Human tissue
Demyelinating lesion evolution was studied in formalin-fixed, paraffinembedded (FFPE) brain tissue from seven autopsy cases: four cases of X-ALD and three cases of MLD obtained from the archives of the Institute of Neuropathology at the University Medical Center Göttingen and of the Department of Neuropathology at the Charité Berlin. The patient data are summarized in Table 1 . For X-ALD, patients with infantile, adolescent and adult variants were analyzed, for MLD we examined two patients with the adult and one with the late infantile variant. We defined the following lesion areas for X-ALD: normal appearing white matter, prelesional areas with changes in microglia number and immune phenotype but largely unaltered myelin and oligodendrocytes, actively demyelinating areas where major myelin breakdown occurred, and early and advanced gliotic areas characterized by progressive astrocytic scarring. In MLD prelesional areas as described above, transition areas, defined by a characteristic enlarged phagocyte morphology and early and advanced gliotic areas were distinguished. In cases of very advanced disease, the entire white matter was demyelinated and dominated by fibrous astrogliosis. These cases were classified as containing predominantly late lesion areas (early and advanced gliotic areas). Cases in early disease stages, in contrast, showed subcortical white matter without overt myelin alterations, and revealed different areas of lesion development with a gradual increase in tissue pathology. These cases with evolving lesion areas (normal appearing white matter, prelesional, actively demyelinating and transition areas) as well as scar tissue areas (early and advanced gliotic areas) were classified as containing early and late stage lesion areas (Table 1) . Tissue of 14 cases without confounding CNS pathology, aged between 8 and 65 years, served as controls (Table 1) . The study was approved by the ethical review committee of the University Medical Center Göttingen (#24/4/15).
| Histology and immunohistochemistry
All sections were stained with haematoxylin and eosin (HE) and Luxol fast blue/periodic-acid Schiff (LFB/PAS) and Bielschowsky silverimpregnated according to standard procedures to assess cellularity, myelin, and axonal density, respectively. Immunohistochemistry (IHC) was performed with primary antibodies against proteolipid protein (PLP, kind gift of Dr. Klaus-Armin Nave, Göttingen, Germany, 1:500), (TUNEL) was used to detect DNA fragmentation as described previously (Stadelmann, Bruck, Bancher, Jellinger, & Lassmann, 1998) .
| Morphometric analysis
Lesion areas were selected on the basis of the characteristics described below using LFB/PAS staining and immunohistochemistry for Ki-M1P
and myelin proteins (MBP, MAG, MOG, CNPase, and PLP). Borders of specific lesion areas were outlined on sections where IHC for microglia/ macrophage markers had been performed, and cell densities were determined using a 10 × 10 ocular morphometric grid at a 400× magnification (Olympus, Japan). 
| RESULTS
In the present study, we took advantage of a cohort of patients with X-ALD and MLD and applied new and established microglia markers in combination with oligodendrocyte, myelin, axon, and astrocyte histo-and immunohistochemistry for a better understanding of lesion development with a particular focus on phagocyte immune phenotypes. In our X-ALD and MLD cases we observed extensive, confluent white matter pathology extending from periventricular brain regions to the cortex, with central brain regions showing the most advanced tissue destruction. Lesion characteristics and lesion evolution are described and compared separately for the diseases. were substantially reduced in number, and APP+ axonal profiles were less frequently seen than in the prelesional area, most likely also reflecting the reduction in axon number.
3.2 | Phagocytes in the demyelinated lesion center re-adopt a surveillant microglia shape and marker profile in X-ALD Adjacent to this frequently large zone of active demyelination, we observed areas of intense astrocytic scarring. Early gliotic scar regions (area EG in Figure 1a ,b) showed Ki-M1P+ phagocytes that were mostly amoeboid in shape and often enriched within the perivascular spaces. In this region and even more in fully demyelinated, advanced gliotic scar areas (AG in Figure 1a ) of patients in advanced disease stages, phagocyte numbers progressively returned to levels of normalappearing white matter and age-matched controls ( Interestingly, we found evidence here of recent myelin phagocytosis The sequence of lesion evolution in MLD appeared less orderly than in X-ALD, with patches of earlier lesion stages interspersed between Figure 4c ). However, on a centripetal lesion axis, oligodendrocyte numbers progressively declined, eventually reaching levels comparable to advanced gliotic lesion areas in X-ALD (28.6 ± 5.2 TPPP/p25+ cells/mm 2 in MLD advanced gliotic areas, patient LD6). In the early and advanced gliotic scar areas, both myelin and axons were severely reduced. There were no apparent signs of remyelination in early or advanced gliotic areas.
| Characterization of cell death in different lesion areas
In both leukodystrophies we found a clear reduction in phagocyte density in specific lesion areas. We were interested to detect whether this was due to phagocyte death. TUNEL staining, initially viewed as an indicator of apoptosis, appears to be sensitive to different forms of newly discovered programmed cell death pathways (Tonnus & Linkermann, 2017) . We therefore applied the TUNEL method as a screening tool of phagocyte cell death in combination with Ki-M1P-immunohistochemistry in different lesion areas. In addition, to dissect which cell death pathways were activated in the respective diseases we applied antibodies against caspase 1 for caspase 1-dependent pyroptosis and active caspase 3 for classical apoptosis.
In X-ALD we did not find relevant signs of TUNEL-sensitive cell death in the normal appearing white matter. In contrast, many phagocytes harbored DNA fragmentation in the prelesional area (52.4 ± 11.8% of Ki-M1P+ cells in prelesional area, patient LD1), but only very few oligodendrocytes or astrocytes, situated mostly at the border to the next following area, were TUNEL+. Staining was often rather diffuse, including parts of the cytoplasm. Cells were, however, negative for caspase 1 and active caspase 3 IHC, and the nucleus was typically not condensed
). These observations suggest that the reduction in microglia density in the prelesional area in X-ALD is largely due to microglia death that precedes the decay of oligodendrocytes.
In MLD, in the prelesional areas, moving towards the center of the lesion, progressively more cells labelled with TUNEL (47 ± 7.5% of Ki-M1P+ cells in late prelesional area, patient LD7). Here, the staining pattern in Ki-M1P+ phagocytes was diffuse and cytoplasmic and there was hardly any labeling of oligodendrocytes or astrocytes (Figure 5k ). In the transition area we found much fewer TUNEL+ cells.
In the early gliotic scar areas, however, we again observed many TUNEL+ phagocytes, but with a different phenotype. Cells showed TUNEL reactivity restricted to the nucleus with clear, TUNEL-negative cytoplasm (Figure 5l , nuclear TUNEL staining in 36.4 ± 7,12% of Ki-M1P+ cells, cytoplasmic TUNEL staining in 5.6 ± 3.5% of Ki-M1P+ cells in early gliotic areas, patient LD7). Caspase 1 and active caspase 3 immunoreactivity were not detected in these cells. Here in early gliotic areas, in addition many oligodendrocytes and astrocytes were TUNEL+.
| DISCUSSION
A central issue in research on microglia and monocytes in the brain is the enormous plasticity of these cells. It is thus a considerable challenge to define the specific molecular signatures with which brain phagocytes can be allocated to cellular subcategories, such as activation status (Hanisch & Kettenmann, 2007; Martinez & Gordon, 2014) , stage of maturation or aging (Butovsky et al., 2014; Matcovitch-Natan et al., 2016; Streit, Xue, Tischer, & Bechmann, 2014) , and location and origin (Brendecke & Prinz, 2015; Gomez Perdiguero et al., 2015; Prinz & Priller, 2014; Silvin & Ginhoux, 2018; Tay, Hagemeyer, & Prinz, 2016) .
Classic microglia markers such as Iba1 (Ito et al., 1998) (Bennett et al., 2016; Butovsky et al., 2014; Mildner, Huang, Radke, Stenzel, & Priller, 2017; . Experimental manipulations, however, have demonstrated that their expression is not only dependent on origin, but also on activation status, age and environment (Bennett et al., 2016; Bohlen et al., 2017) . Moreover, it was demonstrated that phagocytes transplanted from other tissues can express these markers after engraftment of the brain (Bennett et al., 2018) , leading to ambiguity in their interpretation in the disease context.
Importantly, in our study these new markers nevertheless enabled the detection and demarcation of early lesion areas in X-ALD and MLD that were not discernible when applying established phagocyte markers, such as Ki-M1P or Iba1, or by relying on myelin and oligodendrocyte phenotype alone. In early X-ALD surveillant microglia in the comparatively large areas of normal appearing white matter did not significantly downregulate the homeostatic marker proteins Tmem119 and P2ry12. In adjacent prelesional areas we observed, apart from substantial microglia reduction, phagocytes that completely lost Tmem119
and P2ry12 expression. The prelesional area was sharply separated from normal appearing white matter by these alterations in phagocyte immune-phenotype. In MLD, in contrast, there was hardly any normal The most striking result of our study, however, was the drastic reduction in and death of microglia in certain evolving lesion areas in X-ALD and MLD that exceeded and preceded oligodendrocyte decay and overt myelin degeneration. Interestingly, the phenotypes of cell death were intrinsically different among the diseases and between lesion stages.
In regard to the early reduction of microglia in prelesional areas in X-ALD, we found that dying cells were TUNEL+, favoring a programmed Importantly, the spread of contrast enhancement into this prelesional area on magnetic resonance imaging occurs on a time scale of months rather than days, as does clinical deterioration (Loes et al., 2003; Melhem, Loes, Georgiades, Raymond & Moser, 2000; Musolino et al., 2012) . This may indicate that the pathology leading to microglia cell death in the prelesional area and the concomitant peripheral phagocyte and lymphocyte invasion in the next adjacent actively demyelinating area develop slowly.
The literature (Eichler et al., 2008; Loes et al., 2003; Melhem et al., 2000; Musolino et al., 2012 ) and the present findings revealing large prelesional areas of reduced phagocyte densities thus suggest that microglia cell death in the early evolving lesions in X-ALD does not result in a significant immediate recruitment of phagocytes, as would be expected in pyroptosis. Instead, immunologically silent or inefficient pathways seem to take place, and substantial phagocyte invasion as well as major tissue destruction only occur in later stages of lesion formation (actively demyelinating area). Potentially, the findings of Jang et al. may apply to these later lesion stages or concur with a tissue microenvironment, where inflammatory cascades are transiently blocked and peripheral cell recruitment is inhibited. In this context it should be noted that the authors report that in vitro 25OH treatment of microglia in the absence of lipopolysaccharides failed to induce IL-1b secretion, thus requiring a strictly pro-inflammatory priming signal. Further research aiming to identify the specific cascades leading to phagocyte death in early X-ALD is crucially needed as this may help understand yet unknown triggers of lesion development, and unravel the mystery of the lacking correlation of genotype and cerebral phenotype in the disease (Berger et al., 2010; Berger, Dorninger, Forss-Petter, & Kunze, 2016; Schluter et al., 2018) .
In MLD we found the alterations in phagocyte density, morphology and immune phenotype in the different stages of lesion development were accompanied by different types of TUNEL staining.
Phagocytes in prelesional areas contained many enlarged vesicles lined with Ki-M1P (CD68), a marker typically found on lysosomal membranes. These cells showed diffuse cytoplasmic TUNEL staining, indicating a leakage of DNA fragments into the cell soma. In contrast, phagocytes in early gliotic areas showed a homogenous Ki-M1P expression pattern in the cell soma but TUNEL staining was restricted to the nucleus. Cells often appeared leaky or even breaking up, and cellular Ki-M1P+ remnants were spread throughout the tissue. There was a continuous and severe diminution in phagocytes across the lesion stages and towards the center of the lesion. Even though we were not able to molecularly identify the specific pathways of programmed cell death, the differences in phenotype and TUNEL pattern described here support the notion that different cascades of phagocyte decay occur in prelesional and early gliotic areas. Interestingly, a diffuse cytoplasmic TUNEL staining in ramified microglia has previously been described in the resolution phase of brain injury when cell numbers return to prior levels (Streit & Xue, 2009 ). In addition, on the basis of the described morphological features alone, it seems likely that in MLD, a massive enlargement of lysosomes in prelesional areas as known to occur in different lysosomal storage diseases (Lüllmann-Rauch, 2005; Xu & Ren, 2015) is followed by a loss of lysosomal compartmentalization accompanied by disintegration of the plasma membrane and breakup of the cell. In early gliotic areas we found a clearly deficient and delayed efferocytosis of cellular remnants.
While defective removal of dead phagocytes is assumed to be detrimental in other conditions such as atherosclerosis (Moore & Tabas, 2011) , its reasons and significance in this disease await further clarification. In a mutant zebrafish model leading to lysosomal dysfunction, an increased volume of vacuolated lysosomes as found in MLD phagocytes had a negative impact on cell motility and clearance function (Berg et al., 2016; Shen, Sidik, & Talbot, 2016) .
Furthermore, it has been demonstrated that defects of lysosomes in microglia lead to the accumulation of lipofuscin and impaired phagocytic function (Safaiyan et al., 2016) and that defective lysosomal lipid degradation and removal can hinder efficient tissue regeneration (Cantuti-Castelvetri et al., 2018) . These findings support the notion that the observed lysosome dysfunction in phagocytes could be a major driver of the observed tissue pathology in MLD.
Recently it has been shown in X-ALD that monocytes/macrophages are the metabolically most affected peripheral immune cell type (Weber et al., 2014) and that switches to an anti-inflammatory M2 phenotype after activation are impaired (Weinhofer et al., 2018) .
It is assumed that this functional defect contributes to the prolonged inflammation in cerebral lesions. In line with this we found large actively demyelinating areas in our most acute case of X-ALD (LD1).
However, in advanced gliotic areas, largely devoid of myelin, cells expressing homeostatic microglia markers eventually reappeared that were comparable in number to normal-appearing white matter and controls. The origin of these cells, which appeared slightly dysmorphic compared with normal white matter microglia, is difficult to determine. after differentiation into CNS-resident macrophages as demonstrated recently after irradiation-and chemotherapy-free monocyte transplantation into the brain (Bennett et al., 2018 In X-ALD and MLD, the changes in microglia immune-phenotype and phagocyte death in prelesional areas preceded a major destruction of oligodendrocytes and myelin. However, in X-ALD it was shown recently that cellular stress, indicated by marked upregulation of heat shock proteins, occurs in astrocytes in prelesional regions and before active demyelination (Gortz et al., 2018) . Also, it has to be noted that within prelesional areas of X-ALD (but not MLD), we found tissue alterations such as myelin pallor and vacuolization, condensed though TUNEL-negative oligodendrocyte nuclei, and APP-positive axons. The methods applied here are in addition not suited to detect all subtle metabolic insults to oligodendrocytes and myelin, for example, changes in membrane lipid composition, changes in lipid raft structure or early de-compaction of myelin, which potentially could influence microglia phenotype and disease progression (Peferoen, Kipp, van der Valk, van Noort, & Amor, 2014) . Undegradable substrates in X-ALD and MLD are mainly synthesized in oligodendrocytes and the minor myelin alterations observed in the prelesional area might already reflect a pathology leading to increased myelin turnover. Evidence accumulates that defect and aged myelin is shed from oligodendrocytes and taken up by microglia (Hill, Li, & Grutzendler, 2018; Safaiyan et al., 2016) . Our findings of severe damage and cell death occurring first in microglia supports the hypothesized outsourcing of myelin degradation by oligodendrocytes in the CNS. Furthermore, we find evidence in X-ALD and MLD that, while such a strategy might in early stages lead to the sequestration of toxic material and thereby protection of the surrounding tissue, the ensuing destruction of microglia severely drives tissue pathology.
A general drawback of postmortem autopsy studies is the need to draw conclusions about the temporal sequence of lesion evolution from spatial information of lesion areas, since only one timepoint is available.
No MRI scans of any of the patients in this study were available, so the assumptions about the development of the demyelinating lesions remain in part speculative. However, in X-ALD we were able to examine all lesion stages within one patient, which allowed a good correlation with data from prior autopsy and longitudinal MRI studies with regard to the typical evolution and spread of lesions (Eichler et al., 2009; Loes et al., 1994; Loes et al., 2003; Musolino et al., 2012; Schaumburg, Powers, Raine, Suzuki, & Richardson, 1975; van der Knaap & Valk, 2005) . Moreover, in X-ALD and MLD the observation of cellular features comparable to defined stages of CNS tissue damage in other diseases as for example, the acuteness of monocyte infiltration in necrotic brain areas and in autoimmune demyelinating diseases (Brück et al., 1995) , and stage-dependent astrocyte morphology in scar regions (Sofroniew & Vinters, 2010) provide further evidence that our spatial sequence of lesion areas indeed corresponds to a temporal order of lesion evolution.
In the last century, seminal work on MLD and X-ALD established a first subdivision of lesions into different areas according to phagocyte and myelin morphology (Peiffer, 1959; Schaumburg et al., 1975) . New microglia markers help us refine these descriptions, with surprising results. It is striking that in MLD, the loss of phagocytes is more dramatic in many lesion stages than that of mature oligodendrocytes and that in MLD and X-ALD phagocyte death precedes the decay of oligodendrocytes. We believe this indicates a pivotal-and underestimated-role of microglia in these diseases.
In conclusion, our data are not only relevant for the histopathological staging of lesion evolution in these diseases but may also serve as a basis for further research into the specific pathology of microglia in hereditary leukodystrophies, with a focus on the nature of the initial microglia alterations and the molecular pathways leading to their demise.
